Citizens Financial Group Inc. RI Has $727,000 Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Citizens Financial Group Inc. RI increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 11.7% during the third quarter, HoldingsChannel reports. The fund owned 6,588 shares of the medical device company’s stock after buying an additional 688 shares during the quarter. Citizens Financial Group Inc. RI’s holdings in Cooper Companies were worth $727,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of COO. Ashton Thomas Securities LLC bought a new stake in shares of Cooper Companies in the third quarter worth $25,000. Covestor Ltd raised its position in Cooper Companies by 305.9% during the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock worth $28,000 after purchasing an additional 208 shares during the last quarter. Innealta Capital LLC acquired a new position in Cooper Companies during the 2nd quarter worth about $25,000. Crewe Advisors LLC grew its position in shares of Cooper Companies by 286.4% in the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after buying an additional 252 shares during the last quarter. Finally, Tortoise Investment Management LLC increased its stake in shares of Cooper Companies by 75.4% in the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock valued at $34,000 after buying an additional 169 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Wells Fargo & Company lifted their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Morgan Stanley increased their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Tuesday, September 10th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday. Robert W. Baird boosted their price objective on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday, August 29th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Stock Up 0.9 %

Cooper Companies stock opened at $100.80 on Friday. The firm has a market capitalization of $20.08 billion, a price-to-earnings ratio of 56.16, a price-to-earnings-growth ratio of 2.14 and a beta of 0.99. The firm’s fifty day moving average price is $105.91 and its two-hundred day moving average price is $98.26. The Cooper Companies, Inc. has a 1-year low of $82.21 and a 1-year high of $112.38. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.05. The business had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.84 EPS. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Insider Activity at Cooper Companies

In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the transaction, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at $520,488.54. This trade represents a 24.94 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. This represents a 72.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 256,373 shares of company stock valued at $27,637,427 over the last 90 days. Insiders own 2.00% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.